Takeover vs. a long slow grindIf someone were to offer $10 next week I would sell without hesitation. It’s either that or a long slow grind as sales ramp up at a snail’s pace.
I wonder where TH would be at if the Trogarzo deal never happened? With just a pure focus on Egrifta over the last two years, surely, we would be trading with a $4 or $5 handle. How can management be satisfied with their performance? How can the board be satisfied with the performance? It is absolutely ridiculous.
I for one would be happy to be rid of my shares at anything above $10 at this point and that is disappointing. To have two approved drugs, with significant growth opportunities and because of management’s lack of execution we are trading at pre Trogarzo approval levels.